Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group

Introduction The risk of HBV reactivation is important in lymphoma patients receiving immunosuppressive chemotherapy containing steroids or anti-CD20 antibodies. We aimed to establish the prevalence of HBV Ag and anti-HBc serologic positive results in patients with non-Hodgkin lymphoma (NHL) and chr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ewa Kalinka, Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Joanna Barankiewicz, Elżbieta Zalewska, Igor Symonowicz, Ewa Lech-Marańda
Format: article
Langue:EN
Publié: Termedia Publishing House 2019
Sujets:
R
Accès en ligne:https://doaj.org/article/ce78f69cb9b744468c38171ba90af4e1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!